Catalyst Wire Dossier Catalyst Wire Dossier

SUBLOCADE

buprenorphine extended-release · Indivior Inc.
Drug timelines are a Plus or Pro feature.

35 regulatory and trial events tracked for SUBLOCADE, covering 2017-01-31 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic [Phase 4]

See pricing